Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Noble Life Sciences

Noble Life Sciences
2010 FOUNDED
PRIVATE STATUS
Grant LATEST DEAL TYPE
$100K LATEST DEAL AMOUNT
3 INVESTORS
Description

Provider of GLP and non-GLP services designed to accelerate development for drugs, vaccines and medical devices. The company's GLP and non-GLP services include experimental design and testing, early safety assessments, toxicology and vivarium services, enabling physicians to do safety and efficacy testing of any drug candidate.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Healthcare Services
Biotechnology
Primary Office
  • PO Box 242
  • Woodbine, MD 21797
  • United States

+1 (800) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Noble Life Sciences’s full profile, request a free trial.

Noble Life Sciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 14-Jan-2014 $100K 00000 Completed Startup
2. Debt - General 11-Jun-2013 00000 Completed Startup
1. Seed Round 30-Mar-2012 $235K $235K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Noble Life Sciences Competitors (21)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PRC Clinical Corporation Burlingame, CA
000 00000000 Formerly PE-Backed Newark, DE 0000 000000000 00
0000000000 Private Equity-Backed Princeton, NJ 0000 000.00 000000000000 000.00
000000 000000000 0 Private Equity-Backed Albany, NY 0000 00.000 000000000 00.000
0000 000000 Formerly PE-Backed Shanghai, China 00000 00.000 0000 00.000
To view this company’s complete list of competitors, request access »

Noble Life Sciences Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000 0000 03-Dec-2014 000000000000000000 Other Healthcare Services 00000 000000000
SynAm Vaccine 16-Apr-2013 Grant 0000 Other Pharmaceuticals and Biotechnology
To view this company’s complete investment and acquisition history, request access »

Noble Life Sciences Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
TEDCO Venture Capital Minority 000 0000 000000 0
BroadOak Capital Partners Investment Bank Minority 000 0000 000000 0
Noble BioVentures Venture Capital Minority 000 0000 000000 0

Noble Life Sciences Executive Team (11)

Name Title Board
Seat
Contact
Info
Srujana Cherukuri Ph.D Chief Executive Officer
Janet Kelley Controller
Casimir Eitner Senior Vice President, Corporate Development
Alain Cappeluti Co-Founder & President
Stephen Horrigan Ph.D Chief Scientific Officer

2 Former Executives

You’re viewing 5 of 11 executives. Get the full list »

Noble Life Sciences Board Members (1)

Name Representing Role Since Contact
Info
Kenneth Carter Ph.D Self Co-Founder & Chairman 000 0000